文献速递白内障与屈光手术

评估白内障手术成功指标的效力与推广性

Evaluating Metrics Assessing Surgical Success in Patients Undergoing Cataract Surgery.
PubMed 文献 · JAMA Ophthalmol · 2026-01-01

结果显示90.7%患者达到成功标准,但该措施排除了近半数患者,且年长和黑人患者更易被排除,提示需进行病例组合调整以确保公平比较。

要点

  • MIPS措施191定义的成功率为90.7%,但排除了46.4%有眼部共病的患者。
  • 社会经济弱势、复杂手术、联合手术和糖尿病与手术成功几率降低相关。
  • 年长和黑人患者更可能被排除在措施评估之外,需病例组合调整。

核心结论

  • 多数白内障手术患者达到MIPS措施191的成功标准,但该措施排除了近半数手术患者。
  • 年长和黑人患者更可能被排除,病例组合调整可能对公平比较术者表现是必要的。

主要发现

  • 居住在最不富裕社区(OR 0.81;95% CI 0.72-0.91)、复杂手术(OR 0.82;95% CI 0.75-0.89)、白内障联合其他眼内手术(OR 0.32;95% CI 0.29-0.35)及糖尿病(OR 0.90;95% CI 0.84-0.98)与较低的手术成功几率相关。

关键数值与推荐

  • MIPS措施191定义手术成功为术后90天内最佳记录视力至少20/40。
  • 仅评估第一只手术眼(对双眼手术患者)。

临床怎么用

  • 在利用MIPS措施191比较术者表现时,应考虑患者社会经济特征和临床因素进行病例组合调整。

局限性

  • 研究为回顾性设计,可能受数据完整性影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: As health insurers, payers, and policymakers look to Merit-Based Incentive Payment System (MIPS) measures to judge eye care quality, compare surgeon performance, and make decisions about reimbursement, it is essential to understand the validity and generalizability of these metrics. OBJECTIVE: To assess the validity and generalizability of 2024 MIPS measure 191, Cataracts: 20/40 or Better Visual Acuity Within 90 Days Following Cataract Surgery. DESIGN, SETTING, PARTICIPANTS: This was a retrospective cohort study of patients who underwent at least 1 cataract surgery from 2010 through 2023 at any of 16 participating health systems in the Sight Outcomes Research Collaborative (SOURCE). The study assessed whether patient demographic characteristics and nonclinical and clinical factors were associated with achieving success, which MIPS measure 191 defines as a best recorded visual acuity of at least 20/40 within 90 days following cataract surgery. Data analysis was conducted from June 2024 to December 2025. EXPOSURES: Cataract surgery. MAIN OUTCOMES AND MEASURES: The percentage of patients undergoing cataract surgery achieving success and the odds of surgical success were determined; for patients with 2 operative eyes, only the first eye surgery was assessed. Success rates were evaluated among all surgery recipients and separately among patients with no preexisting chronic ocular diseases as specified by the metric. Success rates were quantified using more stringent cutoffs and adjusting the follow-up duration. Logistic regression models assessed how nonbiological determinants of health and clinical factors influenced the odds of success. RESULTS: A total of 55 132 patients underwent cataract surgery (mean [SD] age, 70.3 [9.3] years; 32 240 [58.5%] female; 1973 [3.6%] Asian American; 7053 [12.8%] Black; 1993 [3.6%] Hispanic; 42 178 [76.5%] White [race and ethnicity were self-reported]). Among all patients undergoing surgery, 49 979 (90.7%) achieved surgical success. Excluding patients with ocular comorbidities (25 563 patients [46.4%]), 28 242 of 29 569 (95.5%) achieved surgical success. Living in the least (vs most) affluent community (odds ratio [OR], 0.81; 95% CI, 0.72-0.91), undergoing complex surgery (OR, 0.82; 95% CI, 0.75-0.89) or a combination of cataract with another intraocular surgery (OR, 0.32; 95% CI, 0.29-0.35), and having diabetes (OR, 0.90; 95% CI, 0.84-0.98) were associated with lower odds of surgical success. CONCLUSIONS AND RELEVANCE: In this cohort study, most patients undergoing cataract surgery achieved success as defined by MIPS measure 191; however, the existing measure excluded nearly half of patients undergoing surgery, and older patients and Black patients were more likely to be excluded. Case-mix adjustment of patients' sociodemographic characteristics and clinical factors may be necessary to ensure fairness when comparing surgeons' performance.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Li Y, French DD, Chaudhury AS, et al. Evaluating Metrics Assessing Surgical Success in Patients Undergoing Cataract Surgery. JAMA Ophthalmol. 2026. PMID: 41989790. doi:10.1001/jamaophthalmol.2026.0845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。